Regulatory Updates
🇪🇺 EMA Page 6EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 61–72 of 171 articles
EMA's CHMP Recommends Oral Wegovy Approval, Expanding Obesity Treatment Options in Europe
FDA Approves AstraZeneca's Imfinzi-BCG Combination for High-Risk NMIBC
ASCO26: Summit, Akeso claim OS victory for ivonescimab in pivotal Chinese study
Medscape's AI Integration in Hematology: A Catalyst for Change at EHA 2026
OS Therapies Publishes Four Articles on OST-HER2 and Osteosarcoma, Signaling Clinical Progress
BioCryst Presents New HAE Data for ORLADEYO® and Navenibart at EAACI 2026
European Commission Opens 2026 Joint Scientific Consultation Submission Window
Datroway Priority Review Fuels Hope for Metastatic Triple-Negative Breast Cancer Patients
ImmunityBio's Anktiva Expansion: Navigating FDA Decision Dates and Regulatory Hurdles
FDA Approves Baxdrostat (Baxfendy) as First Aldosterone Synthase Inhibitor for Uncontrolled Hypertension
EMA Initiates Implementation of New EU Pharmaceutical Legislation: What Pharma Needs to Know
Regeneron Pharma Stock Holds Steady Amid EMA Eye Drug Review and Analyst Target Adjustment